Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
PC

PCRX

Market Closed

Pacira BioSciences, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic
US
827 employees
CEO: Frank D. Lee
Founded: 2011
$25.36
+$0.00(+NaN%)
Market Cap
997.54M
Beta
0.27
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
79.4%
8.7%
CAGR: 9.5%

Profit after direct costs

Operating Margin
4.6%
-145.4%
CAGR: -22.0%

Core business profitability

Net Margin
1.0%
-107.1%
CAGR: -36.0%

Bottom line profitability

Revenue Growth
3.6%
YoY
CAGR: 7.6%

Top line growth rate

Revenue Flow Analysis
Visual flow showing how PCRX allocates revenue across expenses and profit
Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin
79.4%
$576.66M
Operating Margin
4.6%
$33.30M
Net Margin
1.0%
$7.03M
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
ItemTrend20212022202320242025YoY Change
Total Revenue
541.53M666.82M674.98M700.97M726.41M3.6%
Cost of Revenue
(140.25M)(199.29M)(184.67M)(170.43M)(149.75M)-12.1%
Gross Profit
401.28M467.53M490.31M530.54M576.66M8.7%
Operating Expenses
Research & Development
(55.55M)(84.80M)(76.26M)(81.58M)(117.31M)43.8%
Selling, General & Administrative
(199.34M)(254.52M)(269.44M)(294.10M)(368.76M)25.4%
General & Administrative
(88.32M)(109.52M)(116.40M)(122.08M)(142.14M)16.4%
Selling & Marketing
(111.02M)(145.00M)(153.04M)(172.01M)(226.62M)31.7%
Depreciation & Amortization
(28.55M)(91.50M)(75.57M)(78.78M)(91.02M)15.5%
Operating Income (EBIT)
89.92M60.02M87.67M-73.37M33.30M-145.4%
Non-Operating Items
Interest Income
896.00K4.54M11.44M19.69M22.73M15.5%
Interest Expense
(29.00M)(35.58M)(17.31M)(16.57M)(14.61M)-11.8%
Other Income/Expenses (Net)
-33.52M-46.72M-25.97M10.27M-16.43M-260.0%
Income Before Tax
56.40M13.30M61.70M-63.11M16.87M-126.7%
Income Tax Expense
(14.42M)(2.61M)(19.75M)(36.45M)(9.84M)-73.0%
Net Income
41.98M15.91M41.95M-99.56M7.03M-107.1%
Per Share Metrics
Earnings Per Share (Basic)
$1$0$1$-2$0-107.4%
Weighted Avg Shares Outstanding
44.26M45.52M46.22M46.24M44.57M-3.6%
Weighted Avg Shares Outstanding (Diluted)
45.63M46.54M51.98M46.24M45.04M-2.6%
EBITDA
113.95M140.38M154.59M29.12M122.50M320.7%

Explore PCRX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PCRX in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →